Regeneron is to pay $256 million in cash to acquire "substantially all" of 23andMe's assets, including its massive biobank of around 15 million customer genetic samples and data.

you are viewing a single comment's thread
view the rest of the comments
[–] -5 points 1 year ago

Standard hexbear user.

  • source
  • parent